Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology.

MLA

Alfredo, Martínez‐Gutiérrez, et al. “Depigmenting Topical Therapy Based on a Synergistic Combination of Compounds Targeting the Key Pathways Involved in Melasma Pathophysiology.” Experimental Dermatology, vol. 32, no. 5, May 2023, pp. 611–19. EBSCOhost, https://doi.org/10.1111/exd.14752.

APA

Alfredo, M., Maribel, P., Eloy, P., Susana, G., Luis, L. G. S., & Carmen, G. M. (2023). Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved in melasma pathophysiology. Experimental Dermatology, 32(5), 611–619. https://doi.org/10.1111/exd.14752

Chicago

Alfredo, Martínez‐Gutiérrez, Pérez‐Martínez Maribel, Pena‐Rodríguez Eloy, Gómez‐Escalante Susana, Luis G. S. Luis, and González Mari Carmen. 2023. “Depigmenting Topical Therapy Based on a Synergistic Combination of Compounds Targeting the Key Pathways Involved in Melasma Pathophysiology.” Experimental Dermatology 32 (5): 611–19. doi:10.1111/exd.14752.